NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
16.07
-0.36 (-2.16%)
Jul 17, 2026, 12:45 PM EDT - Market open
NovoCure Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -173.05 | -136.23 | -168.63 | -207.04 | -92.53 | -58.35 |
Depreciation & Amortization | 15.45 | 14.65 | 11.24 | 10.97 | 10.62 | 10.25 |
Stock-Based Compensation | 138.29 | 104.83 | 160.04 | 115.61 | 106.96 | 94.9 |
Other Adjustments | -7.15 | -12.21 | -25.36 | -22.53 | -6.05 | 6.89 |
Change in Receivables | -29.5 | -38.94 | -26.36 | 29.41 | 2.55 | 5.27 |
Changes in Inventories | -4.51 | -5.67 | 2.57 | -8.92 | -4.34 | 2.48 |
Changes in Accrued Expenses | 30.26 | 18.96 | 19.11 | 14.87 | 14.26 | 27.78 |
Changes in Other Operating Activities | 3.32 | 5.57 | 1.04 | -5.71 | -0.67 | -6.46 |
Operating Cash Flow | -26.88 | -49.03 | -26.37 | -73.34 | 30.79 | 82.76 |
Operating Cash Flow Growth | - | - | - | - | -62.80% | -16.53% |
Capital Expenditures | -21.19 | -26.65 | -42.86 | -27.09 | -21.36 | -24.17 |
Purchases of Investments | -802.32 | -821.08 | -875.39 | -1,004 | -1,298 | -1,079 |
Proceeds from Sale of Investments | 1,275 | 1,285 | 778 | 1,215 | 1,179 | 958 |
Investing Cash Flow | 451.5 | 437.28 | -140.24 | 184.15 | -139.96 | -144.83 |
Long-Term Debt Issued | 99.98 | 99.98 | 96.92 | - | - | - |
Long-Term Debt Repaid | -560.95 | -560.95 | -12.91 | -0.01 | -0.03 | -0.03 |
Net Long-Term Debt Issued (Repaid) | -460.97 | -460.97 | 84.01 | -0.01 | -0.03 | -0.03 |
Issuance of Common Stock | 4.91 | 9.77 | 6.31 | 15.8 | 15.52 | 25.73 |
Net Common Stock Issued (Repurchased) | 4.91 | 9.77 | 6.31 | 15.8 | 15.52 | 25.73 |
Other Financing Activities | - | -0.15 | - | - | - | - |
Financing Cash Flow | -456.76 | -451.34 | 90.32 | 15.79 | 15.49 | 25.7 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.04 | 0.39 | -0.17 | 0.13 | -0.1 | -0.19 |
Net Cash Flow | -32.11 | -62.7 | -76.47 | 126.73 | -93.78 | -36.56 |
Free Cash Flow | -48.07 | -75.68 | -69.22 | -100.43 | 9.43 | 58.59 |
Free Cash Flow Growth | - | - | - | - | -83.90% | -30.40% |
FCF Margin | -7.13% | -11.55% | -11.44% | -19.72% | 1.75% | 10.95% |
Free Cash Flow Per Share | -0.43 | -0.68 | -0.64 | -0.94 | 0.09 | 0.56 |
Levered Free Cash Flow | -610.68 | -590.33 | -93.53 | -222.94 | -94.05 | -48.5 |
Unlevered Free Cash Flow | -157.75 | -146.91 | -228.11 | -267.34 | -102.7 | -39.8 |